NCT00984581View on ClinicalTrials.gov

Safety and Efficacy Study of Avotermin (Juvista) in Female Subjects

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

April 30, 2003

Primary Completion Date

August 31, 2004

Study Completion Date

August 31, 2004

Conditions
CicatrixWound Healing
Interventions
DRUG

Avotermin

Intradermal injection, 5ng/100ul/linear cm wound margin administered on Day 0, Day 1 and month 6

DRUG

Avotermin

Intradermal injection, 50ng/100ul/linear cm wound margin administered on Day 0, Day 1 and month 6

DRUG

Placebo

Intradermal injection, 100ul/linear cm wound margin administered on Day 0 and Day 1

Trial Locations (1)

M13 9XX

Renovo, Manchester

All Listed Sponsors
lead

Renovo

INDUSTRY

NCT00984581 - Safety and Efficacy Study of Avotermin (Juvista) in Female Subjects | Biotech Hunter | Biotech Hunter